USPTO Examiner ZIEGLER MATTHEW D - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18643411MASSAGE GUN AND MASSAGE GUN EXTENSION ARMApril 2024September 2025Abandon1710NoNo
18439697UNIVERSAL RESPIRATORY DETECTORFebruary 2024December 2024Allow1000NoNo
18402621VENTILATORJanuary 2024June 2025Abandon1810NoNo
18524605ACOUSTICAL GUIDANCE AND MONITORING SYSTEMNovember 2023February 2026Abandon2620YesNo
18512200ACTUATOR FOR PHYSICAL THERAPYNovember 2023December 2025Allow2520NoNo
18488151SYSTEM AND METHOD OF USE FOR HALOTHERAPY SESSIONSOctober 2023September 2024Allow1110NoNo
18472792AUTO-FIT MASKSeptember 2023October 2025Allow2530YesNo
18468755SEAL FOR AN INHALATION DEVICESeptember 2023August 2025Allow2320YesNo
18202415CARDIOPULMONARY RESUSCITATION APPARATUS CONTROLLED BY HUMAN VITAL SIGNSMay 2023May 2025Abandon2440NoNo
18201113AIRWAY DEVICEMay 2023March 2025Abandon2230NoNo
18315586WEARABLE DEVICE FOR DELIVERING AIRMay 2023May 2024Allow1310NoNo
18309918Selectable, Configurable and Interchangeable Massage Tool Head System For Percussion Massage DevicesMay 2023April 2024Allow1210NoNo
18098921Dual Suction TubeJanuary 2023June 2025Allow2940YesNo
18145682UNIVERSAL RESPIRATORY DETECTORDecember 2022September 2023Allow910NoNo
18079909RELAXATION AND HEALTHCARE SOFADecember 2022January 2025Abandon2540YesNo
17924806APPARATUS AND METHOD FOR SELF-TILT TRAININGNovember 2022March 2026Abandon4010NoNo
18049795ACOUSTICAL GUIDANCE AND MONITORING SYSTEMOctober 2022August 2023Allow1010NoNo
17921097PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING MICROBIAL INFECTIONSOctober 2022February 2026Abandon3910NoNo
17960932Protective Cover SystemOctober 2022January 2026Abandon3930YesYes
17949483Inhalers and Related MethodsSeptember 2022September 2023Allow1210YesNo
17815882GASES MIXING AND MEASURING FOR A MEDICAL DEVICEJuly 2022April 2024Allow2040NoNo
17838773NOZZLE WITH FAN FOR DELIVERING AEROSOLSJune 2022January 2026Abandon4310NoNo
17835784FOREARM SYNERGY TRAINING DEVICEJune 2022October 2025Abandon4120NoNo
17825241AUTO-FIT MASKMay 2022May 2023Allow1210NoNo
17714140Selectable, Configurable and Interchangeable Massage Tool Head System For Percussion Massage DevicesApril 2022January 2023Allow1020YesNo
17656967FLOW MIXERS FOR RESPIRATORY THERAPY SYSTEMSMarch 2022March 2023Allow1110YesNo
17761283Atomizer Device and Method for Preparation Thereof, and a Container ThereforMarch 2022August 2025Abandon4130NoNo
17696410METHODS AND APPARATUS FOR TREATMENT OF RESPIRATORY DISORDERSMarch 2022January 2026Allow4650YesNo
17694563VENTILATORMarch 2022August 2023Allow1720NoNo
17673777Vibration Inducing Sound MatFebruary 2022April 2025Abandon3810NoNo
17672808RESPIRATORY PRESSURE THERAPY SYSTEMFebruary 2022April 2024Allow2630YesNo
17666688Oxygen Mask AssemblyFebruary 2022September 2025Abandon4420NoNo
17591265RESPIRATOR AND METHODS OF USEFebruary 2022June 2025Abandon4110NoNo
17580864MASSAGE APPARATUSJanuary 2022October 2025Abandon4520NoNo
17579398Portable and Compact Hyperbaric ChamberJanuary 2022March 2025Allow3810NoNo
17571364DEVICE FOR SURFACTANT ADMINISTRATION AND VENTILATION OF LOW BIRTH WEIGHT INFANTSJanuary 2022March 2025Abandon3810NoNo
17560764Hyperbaric Chamber Designed for Transport through a Narrow OpeningDecember 2021May 2025Abandon4110NoNo
17552195MASSAGE GUN AND MASSAGE GUN EXTENSION ARMDecember 2021May 2023Abandon1730YesNo
17550168ORO-PILLOW CUSHION ASSEMBLYDecember 2021June 2022Allow610YesNo
17604742MEDICAMENT DELIVERY DEVICEOctober 2021February 2026Allow5220YesNo
17502144ACTUATOR FOR PHYSICAL THERAPYOctober 2021July 2023Allow2110YesNo
17432554SUCTION CATHETER ASSEMBLIES AND ASSEMBLIES INCLUDING A SUCTION CATHETER ASSEMBLYAugust 2021September 2024Abandon3710NoNo
17408085SYSTEM AND DEVICE FOR GUIDING AND DETECTING MOTIONS OF 3-DOF ROTATIONAL TARGET JOINTAugust 2021January 2023Allow1710NoNo
17383753DROPLET ISOLATION ENDOSCOPY MASKJuly 2021January 2026Abandon5420YesNo
17367777Face Mask Communication SystemJuly 2021March 2025Abandon4410NoNo
17356430ANTIVIRAL THAT DESTROYS DNA AND/OR RNA OF VIRUSES AND VIROIDSJune 2021April 2025Abandon4610NoNo
17350737UNIVERSAL RESPIRATORY DETECTORJune 2021August 2022Allow1430NoNo
17343191DRIVING SYSTEM FOR CONTROLLING THE MOVEMENT OF AN OBJECT WITH TWO DEGREES OF FREEDOM OF ROTATION AND REHABILITATION MACHINE FOR REHABILITATION OF THE LOWER LIMBS AND THE TRUNK INCORPORATING SUCH A SYSTEMJune 2021March 2023Abandon2110NoNo
17341994THERMAL MODULATION OF AN INHALABLE MEDICAMENTJune 2021September 2024Allow4000YesNo
17334733SLEEP SYSTEM AND SLEEP-INDUCING DEVICE USING CARBON DIOXIDEMay 2021January 2022Allow810NoNo
17234492ULTRASONIC NEBULIZERApril 2021March 2022Allow1030YesNo
17282930Driving device for providing assisted ventilationApril 2021September 2024Abandon4110NoNo
17282956DEMAND VALVE RESTRICTORApril 2021February 2025Abandon4610NoNo
17211023Method of treating painMarch 2021November 2022Allow2030NoYes
17276865ASSEMBLIES AND METHODS FOR DETECTING ACCIDENTAL EXTUBATION OF A TUBEMarch 2021February 2026Allow5950NoNo
17202433APPLICATION OF UV/FIR TO TREAT INFECTIONS IN THE RESPIRATORY TRACTMarch 2021June 2024Abandon3910NoNo
17275267METHOD AND APPARATUS FOR PROVIDING MASSAGE IN KNEE REGIONMarch 2021May 2025Abandon5020NoNo
17181356NASAL CANNULA WITH TURBULATION ELEMENTSFebruary 2021November 2025Allow5760YesNo
17176467Normobaric Hypoxia TrainerFebruary 2021October 2023Abandon3210NoNo
17176531Hyperbaric Chamber Designed for Transport through a Narrow OpeningFebruary 2021April 2025Abandon5020NoNo
17266121HIGH PRESSURE INHALATION DEVICEFebruary 2021January 2026Allow6050YesNo
17167351METHOD FOR CONTROLLING FLUID JET PLUME CHARACTERISTICSFebruary 2021May 2024Abandon4030NoNo
17166530AIRCRAFT OXYGEN SUPPLY UNIT WITH BLISTER PACK TRAYFebruary 2021January 2026Abandon5940YesNo
17152408AMBULATORY TUBE SUPPORT FOR ENDOTRACHEAL TUBINGJanuary 2021August 2023Allow3120YesNo
17259237Wearable Multifunctional Powered Exoskeleton for Cervical Vertebra RehabilitationJanuary 2021April 2024Allow3910NoNo
17259047DEVICE COUNTERJanuary 2021January 2026Allow6030YesNo
17136256MAGNETIC DAMPER AND ONE-WAY VALVE AND ANESTHESIA RESPIRATOR COMPRISING MAGNETIC DAMPERDecember 2020November 2024Abandon4720YesNo
17122189Wall-Mounted Back Care ApparatusDecember 2020March 2024Abandon3920NoNo
17118613END-EXPIRATORY CO2 GUIDED TRACHEAL INTUBATION DEVICEDecember 2020July 2023Allow3110NoNo
17116951DEVICE FOR HEATING ENDOTRACHEAL TUBES PREPARATORY TO NASAL INTUBATIONDecember 2020October 2023Abandon3410NoNo
16972827COUNTERLUNG FOR A REBREATHING APPARATUSDecember 2020March 2025Allow5230YesNo
17113806SUCTION-ENABLED STYLET FOR ENDOTRACHEAL TUBEDecember 2020March 2022Abandon1560YesNo
16953081VAPORIZER DEVICE DOSE CONSUMPTION CONFIGURATIONSNovember 2020June 2024Abandon4310NoNo
17055530TRACHEAL CANNULATION DEVICENovember 2020March 2026Abandon6040NoNo
17094496System and Method for Generating, and Delivering to Standing Users, Therapeutic Acoustic VibrationsNovember 2020March 2024Abandon4030NoNo
17087851MASSAGE ROLLER ASSEMBLYNovember 2020January 2023Allow2700YesNo
17074177Discrete Inhaling DeviceOctober 2020May 2024Abandon4320NoNo
17042782HANDHELD MUSCLE MASSAGERSeptember 2020October 2023Abandon3710NoNo
17030479COMBINATION MOUTHPIECE AND CHEEK SUPPORT FOR USE IN PERFORMING FORCED OSCILLATION TECHNIQUESeptember 2020April 2024Abandon4320NoNo
17015005KNEADING MASSAGE MACHINE CORESeptember 2020December 2023Abandon3920NoNo
16977976TRACHEAL TUBESeptember 2020August 2024Allow4740YesNo
16999473MOUTHPIECE OF A NEBULIZER, AND PORTABLE NEBULIZER THEREOFAugust 2020September 2023Abandon3710NoNo
16994362SYSTEM AND METHOD FOR OPTIMIZATION OF CPR CHEST COMPRESSIONSAugust 2020June 2024Allow4620YesNo
16985829NEGATIVE PRESSURE ORONASAL APPARATUSAugust 2020March 2025Abandon5540NoNo
16967677MULTI-TUBE ADAPTERAugust 2020October 2024Abandon5150YesNo
16941974CARTRIDGE WITH SINGLE-LAYER CONTAINER AND ITS NOZZLE-SHAPED CAP FOR NEBULIZATION INHALATIONJuly 2020November 2023Abandon4020NoNo
16941536COVID-19 Respiratory THERAPY DeviceJuly 2020July 2023Abandon3510NoNo
16932772NEUROMODULATION FOR TREATMENT OF RETINAL, CHOROIDAL AND OPTIC NERVE DISORDERS AND/OR DYSREGULATED REDUCED OCULAR BLOOD FLOW (OBF)July 2020April 2024Allow4521NoNo
16932548CONCENTRATE ADAPTOR FOR VAPORIZER DEVICEJuly 2020June 2023Allow3510NoNo
16954147AIRWAY DEVICEJune 2020February 2023Allow3210YesNo
16890318INFANT CPAP DEVICE, INTERFACE AND SYSTEMJune 2020July 2025Abandon6030NoNo
16879946PATIENT INTERFACE AND METHOD FOR MAKING SAMEMay 2020March 2025Allow5830NoNo
16858187SYSTEM AND METHOD OF USE FOR HALOTHERAPY SESSIONSApril 2020September 2023Allow4120YesNo
16858239ACOUSTICAL GUIDANCE AND MONITORING SYSTEMApril 2020July 2022Allow2730YesNo
16757544SEAL FOR AN INHALATION DEVICEApril 2020June 2023Allow3830YesNo
16838282DRESSING WITH TARGETED LOW-INTENSITY VIBRATIONApril 2020June 2025Abandon6060YesNo
16832655MOBILIZATION TOOL PERSONAL CARE PRODUCT CONTAINERMarch 2020January 2025Allow5750YesNo
16825640Expandable Endotracheal TubeMarch 2020December 2023Abandon4520NoNo
16821539WEARABLE DEVICE FOR DELIVERING AIRMarch 2020November 2020Allow810YesNo
16819537BREATHING EXERCISE DEVICE AND METHODMarch 2020January 2023Abandon3410NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ZIEGLER, MATTHEW D.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
41.9%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
2
(20.0%)
Not Allowed After Appeal Filing
8
(80.0%)
Filing Benefit Percentile
26.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner ZIEGLER, MATTHEW D - Prosecution Strategy Guide

Executive Summary

Examiner ZIEGLER, MATTHEW D works in Art Unit 3785 and has examined 183 patent applications in our dataset. With an allowance rate of 49.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner ZIEGLER, MATTHEW D's allowance rate of 49.2% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ZIEGLER, MATTHEW D receive 2.49 office actions before reaching final disposition. This places the examiner in the 72% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ZIEGLER, MATTHEW D is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +57.6% benefit to allowance rate for applications examined by ZIEGLER, MATTHEW D. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.1% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 17.6% of cases where such amendments are filed. This entry rate is in the 20% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 37% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 27.0% are granted (fully or in part). This grant rate is in the 15% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.